News Center

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 21, 2019-- Ironwood Pharmaceuticals, Inc.  (NASDAQ: IRWD) will present a corporate update at the 8 th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 11:00 a.m. Eastern Time at the Lotte New York Palace in New York .

– Grew 2018 revenue 16% year-over-year to $347 million , driven primarily by U.S. LINZESS ® (linaclotide) collaboration revenue of $264 million and linaclotide API sales of $70 million – – Progressed separation of Ironwood and Cyclerion into two publicly-traded companies with completion expected

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jan. 28, 2019-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its fourth quarter and full-year 2018 investor update conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, February 13, 2019 .

– Important step toward launching two independent, publicly-traded companies – – Separation on track for first half 2019 – CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jan. 28, 2019-- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) today announced the filing by Cyclerion Therapeutics, Inc.